Navigation Links
Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
Date:12/16/2009

About Special Protocol Assessments

The Special Protocol Assessment (SPA) process is a procedure by which the FDA provides official evaluation and written guidance on the design and size of proposed protocols that are intended to form the basis for a new drug application.

Final marketing approval depends on the results of efficacy, the adverse event profile and an evaluation of the benefit/risk of treatment demonstrated in the Phase 3 trial. The SPA agreement may only be changed through a written agreement between the sponsor and the FDA, or if the FDA becomes aware of a substantial scientific issue essential to product efficacy or safety. For more information on Special Protocol Assessment, please visit: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm080571.pdf

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, a key signaling cascade that has been shown to induce cell growth and cell transformation. KRX-0401 has demonstrated both safety and clinical efficacy in several tumor types, both as a single agent and in combination with novel therapies. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK pathway, which are pathways associated with programmed cell death, cell growth, ce
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
3. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
4. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
5. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
6. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
7. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
8. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
9. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
10. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
11. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... China , Sept. 22, 2014 China Nepstar Chain ... a leading retail drugstore chain in China ... it will hold its 2014 Annual General Meeting of Shareholders (the ... AGM will be held at the meeting room of the Company ... Shenzhen , Guangdong Province ...
(Date:9/19/2014)... N.C. , Sept. 19, 2014 ... in forging relationships with key opinion leaders (KOLs) ... and competition. Despite the critical nature of the ... many challenges, including altering the landscape for creating ... According to research, the oversight responsibility for ...
(Date:9/19/2014)... CHAPEL HILL, N.C. , Sept. 19, 2014 /PRNewswire/ ... came to Best Practices, LLC with three issues he ... , The use of external personnel (especially for ... internal headcount in the face of increased workload ... generation and better knowledge management , How to ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 22, 2014 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2In Era of Competing Needs, Market Research Groups Under Pressure to Utilize Automation and External Staffing 2
... Volcano Corporation (Nasdaq: VOLC ), a leading developer and ... treatment of coronary and peripheral vascular disease, said today that it will be ... 10 . , , , ... by Scott Huennekens , president and chief executive officer, will begin at ...
... YORK , Aug. 3 ITelagen, a leading provider of ... by Manhattan ,s Physician Group (MPG) to host, support and manage ... patient data in ITelagen,s SAS-70 Type II certified datacenter and an extension ... , , , ...
Cached Medicine Technology:Volcano Corporation Presentation at Canaccord Genuity Growth Conference to be Webcast 2Manhattan's Physicians Group Selects ITelagen for Hosting and Management of EHR 2Manhattan's Physicians Group Selects ITelagen for Hosting and Management of EHR 3
(Date:9/22/2014)... Pain does not need to rule your life ... reader-friendly book designed to guide the individual who suffers with ... book is written to help the reader who is struggling ... regain a pain-free life — a daily “go-to” guide on ... pain has become an epidemic, with over 100 million Americans ...
(Date:9/22/2014)... YORK (September 22, 2014) Montefiore Medical Center, Albert Einstein ... Women,s Hospital have received a $300,000 grant from The ... the impact of health Information Technology (IT) on patient ... electronic orders, an important clinical patient safety issue impacted ... will be the first time IT leaders have data ...
(Date:9/22/2014)... Ore. Xanthohumol, a type of flavonoid found in ... study to improve cognitive function in young mice, but ... published in Behavioral Brain Research by scientists ... Medicine at Oregon State University. It,s another step toward ... happens with age in many mammalian species, including humans. ...
(Date:9/22/2014)... Medical experts this past weekend gathered ... discuss brain-related diseases facing an aging population, including ... disorders. , Each of the 50 attendees ... memory care community or hospice office. Silverado, with ... hosts the annual event to facilitate the exchange ...
(Date:9/22/2014)... by University of North Carolina at Chapel Hill researchers ... of people who are experiencing the earliest stages of ... the development of severe mental disorders such as schizophrenia. ... affects about 1 in every 100 people. In severe ... a life compromised, and the burden on family members ...
Breaking Medicine News(10 mins):Health News:Naturopathic Doctor Inspires and Guides Those Who Suffer with Chronic Pain, Pointing the Way Back to Pain-free Living 2Health News:AHRQ grant awarded to study the impact of health IT on patient safety at Montefiore and Einstein and Brigham and Women's Hospital 2Health News:Compound from hops aids cognitive function in young animals 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 3Health News:Blood test may help determine who is at risk for psychosis 2
... but a new study shows that the consequences of occasionally ... according to a new study by University of Alabama at ... the Journal of the American Medical Association . ... the United States, according to the National Survey on Drug ...
... By Serena Gordon HealthDay Reporter , TUESDAY, ... more likely to be hospitalized than their peers who don,t ... finds. What,s more, about two-thirds of the hospitalizations ... illnesses, such as a urinary tract infection, the study shows. ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, Jan. 10 ... drinkers -- defined as men who down five or more drinks ... at one time, federal researchers reported Tuesday. Of the 17 ... to 24 years old. But those 65 and older engage in ...
... INDIANAPOLIS -- The School of Science at Indiana University-Purdue ... and Computational Science, an interdisciplinary endeavor dedicated to solving ... environment, and computer science. iM2CS,s parallel mission is to ... scientific issues with which they will be faced. ...
... , TUESDAY, Jan. 10 (HealthDay News) -- Dutch researchers ... the drug Nexavar (sorafenib) in fighting a tough-to-treat form ... experimental drug known as ganetespib showed promise in laboratory ... studies were to be presented Tuesday at an American ...
... Hospital has found that collaborative ,behavioral management may be ... who are paroled. The findings have important implications for ... community correctional population. The study is published in ... print. In the U.S., over 700,000 inmates leave ...
Cached Medicine News:Health News:Marijuana smoke not as damaging to lungs as cigarette smoke 2Health News:Marijuana smoke not as damaging to lungs as cigarette smoke 3Health News:Dementia May Lead to Avoidable Hospitalizations 2Health News:Dementia May Lead to Avoidable Hospitalizations 3Health News:One in Six Americans Binge Drink: CDC 2Health News:One in Six Americans Binge Drink: CDC 3Health News:Revealing causality 2Health News:Mixed News on Tough-to-Treat Lung Cancer 2Health News:Mixed News on Tough-to-Treat Lung Cancer 3Health News:Behavioral management to reduce substance abuse, crime and re-arrest for drug-involved parolees 2Health News:Behavioral management to reduce substance abuse, crime and re-arrest for drug-involved parolees 3
... PW 41 is a powerful, compact ... washers/aspirators, with built-in vacuum and dispensing ... ,are user-adjustable, with vertical and horizontal ... level detectors on wash and waste ...
... LHW is a solid made, manual ... Separate valves for dispense and aspirate ... comes complete with a stand and ... can be used, as well as ...
... ELx50 is a fast and versatile automated strip ... manifold. It is a self contained and programmable ... fluidic delivery from the gentle dripping of a ... pressure delivery systems. ELx50/12V processes 1 x 12 ...
... throughput washer for high ... throughput system washer is ... powerful dispensing line and ... stronger, external vacuum source. ...
Medicine Products: